Webster Brian Daniel 4

What Happened
Brian Daniel Webster, President and Chief Executive Officer of Kestra Medical Technologies, Ltd. (KMTS), was granted 75,681 restricted stock units (RSUs) on June 3, 2026. The RSUs were issued at $0.00 per unit (no cash paid) and will settle into one common share per RSU at vesting. This is an award/grant transaction (code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-03; filing date: 2026-06-04 (timely filing).
• Grant: 75,681 RSUs; reported acquisition price $0.00 (value at grant not reported in filing).
• Vesting: RSUs vest over three years, with one-third vesting on each anniversary of June 3, 2026, subject to continued service.
• Shares owned after transaction: not specified in the provided filing.
• Footnote: RSUs convert to one common share at settlement; these are restricted and subject to vesting conditions.
• Transaction type: Award/Grant (A). Not a sale or purchase of outstanding shares.

Context
RSU grants are a form of equity compensation meant to align executive incentives with shareholder value; they do not represent an immediate cash transaction or sale of shares. Because vesting is time-based and contingent on continued service, these awards do not necessarily indicate near-term buying or selling by the insider.